nav menu
close nav
background
background

NEWS

25 June 2019

Akston Biosciences Receives NIDDK Phase IIb Grant

26 May 2019

Akston Biosciences Begins Buildout of New GMP Biologics Manufacturing Facility

10 May 2019

Akston Biosciences Completes Convertible Note Financing

17 May 2018

Akston Biosciences Completes Series D Preferred Stock Financing

22 February 2018

Akston Biosciences Awarded Phase II SBIR by NIH/NIDDK

16 March 2017

Helmsley Charitable Trust and Akston Biosciences Corporation Announce Partnership to Advance Novel Technology to Treat Type 1 Diabetes